中信重工_Providing professional financial news and data related to 中信重工, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Finance
Haixi Pharmaceuticals (02637.HK): Non-executive Director Wang Xinkun Resigns; Chen Tingze Nominated as Candidate for Executive Director
Finance
China Medical System Holdings(00867.HK): Self-Developed Complement Factor B Inhibitor CMS-D017 Approved for Clinical Trials in AMD Indication
Finance
Fosun Pharmaceutical (02196.HK): Injection FXR0906 Approved for Clinical Trials
Finance
Hopefluent Group (00733.HK): Non-executive Director Li Fuqiang Resigns; Wang Jie Appointed
Finance
Ascletis Pharma(01672.HK): Fixed-Dose Combination of GIPR Agonist ASC48 and GLP-1R Agonist ASC30 Selected for Clinical Development
Finance
Huaneng Power International(00902.HK): Completes Issuance of the 10th Tranche of Super & Short-term Commercial Paper (SCP) of 2026 with Principal of RMB 3 Billion
Finance
HBM Holdings(02142.HK): IND Application of HBM7575 for Asthma Treatment Approved by NMPA
Finance
Inkeverse (03700.HK): Completes Subscription of New Shares Under General Mandate, Net Proceeds of Approximately HK$328 Million
Finance
CapAllianz Holdings: Proposed Acquisition of BODY-MIND Wellness Project, to Issue 2.2 Billion Shares as Consideration
Finance
CIMIC Group: CPB Contractors Selected to Deliver Stage 1 of Toowoomba to Warwick Pipeline

Scan QR Code

Download App